CMB 0.00% 33.5¢ cambium bio limited

Ann: Regeneus Company Update Investor Webcast Presentation

  1. 3,370 Posts.
    lightbulb Created with Sketch. 686
    Fantastic presentation.

  2. 172 Posts.
    lightbulb Created with Sketch. 52
    I have to agree with you. That's RGS's best presentation in 2 years.
    Clear, timeframed, and above all exciting.
    One can see the critical role that Dr Blaber (who just re-joined RGS) is going to have as Clinical Director.

    This presentation makes think RGS has finally moved from R&D company only, then R&D + partnership (Kyocera) to finally a clinical biotech which has the financial resources to back their claims and discoveries.

    Impressive
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
0.000(0.00%)
Mkt cap ! $3.996M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 5273 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 4954 1
View Market Depth
Last trade - 10.02am 03/09/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.